| Trial ID: | L0576 |
| Source ID: | IRCT2016060628299N1
|
| Associated Drug: |
Sigma quercetin
|
| Title: |
The effect of quercetin supplementation on liver enzymes, inflammation indices, lipid profile and body composition, acompaind by colori control in nonalcoholic fatty liver disease:
A randomized, double-blind, pilot study
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver Disease. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: Sigma quercetin supplements, 500 mg per day for 55 people in the intervention group for three months?Be taken on an empty stomach. Intervention 2: placebo supplement containing starch but looks completely like the original supplementation
|
| Outcome Measures: |
Lipid profile. Timepoint: at first and the end of study. Method of measurement: enzymathic method.;Liver enzymes. Timepoint: at first and the end of study. Method of measurement: enzymathic method.;Inflammatory markers. Timepoint: at first and the end of study. Method of measurement: ELISA method.Body composition. Timepoint: at firt of the study and the end of forth,eighth and Twelfth weeks. Method of measurement: BIA.;Weight. Timepoint: at firt of the study and the end of forth,eighth and Twelfth weeks. Method of measurement: With light clothing and using Seca scales with 100 gAccuracy.;Height. Timepoint: Accuracy. Method of measurement: ???? ??? ?? ??????? ?? ?? ??? ??? ?? ??? 0.1 ????? ???.;Waist circumference. Timepoint: at firt of the study and the end of forth,eighth and Twelfth weeks. Method of measurement: Using a tape measure between the lowest gear and iliac crest with accuracy of 0.5 cm.;Hip circumference. Timepoint: at firt of the study and the end of forth,eighth and Twelfth weeks. Method of measurement: Using a tape measure at the bigest part of the hips.
|
| Sponsor/Collaborators: |
Kermanshah University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 years65 years
|
| Phases: |
Not applicable
|
| Enrollment: |
110
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive.
|
| Start Date: |
13/07/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/22980
|
